OSM and inflammatory bowel disease: Interestingly, the expression levels of the pro-inflammatory cytokine oncostatin M (OSM) by macrophages and its receptor OSMR by PDPN+ myofibroblasts, are highly correlated with the degree of severity of IBD and is linked to anti-TNFα therapy resistance [74].